JP2015533801A5 - - Google Patents

Download PDF

Info

Publication number
JP2015533801A5
JP2015533801A5 JP2015531511A JP2015531511A JP2015533801A5 JP 2015533801 A5 JP2015533801 A5 JP 2015533801A5 JP 2015531511 A JP2015531511 A JP 2015531511A JP 2015531511 A JP2015531511 A JP 2015531511A JP 2015533801 A5 JP2015533801 A5 JP 2015533801A5
Authority
JP
Japan
Prior art keywords
alkyl
branched
linear
aryl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015531511A
Other languages
English (en)
Other versions
JP2015533801A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/067509 external-priority patent/WO2014040837A1/en
Publication of JP2015533801A publication Critical patent/JP2015533801A/ja
Publication of JP2015533801A5 publication Critical patent/JP2015533801A5/ja
Pending legal-status Critical Current

Links

Description

(式中、Rは、直鎖または分岐(C−C16)アルキル、直鎖または分岐(C−C18)アルケニル、−OR、アリール、アリール(C−C16)アルキル、−SR、−N(R)(R)、(C−C)シクロアルキル、(C−C)ヘテロシクロアルキルおよびヘテロアリールからなる群より選択され、ここで一または二以上の水素原子が(C−C)アルキルで任意に置換され、RおよびRは、独立して、Hまたは直鎖もしくは分岐(C−C)アルキルから選択され、R6は、直鎖または分岐(C−C16)アルキルであり、
は、一または二以上のハロゲン原子で任意に置換されているアリールである)、および、薬学的に許容されるそれらの塩に関する。
JP2015531511A 2012-09-13 2013-08-23 イソキサゾリジン誘導体 Pending JP2015533801A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12184286.8 2012-09-13
EP12184286 2012-09-13
PCT/EP2013/067509 WO2014040837A1 (en) 2012-09-13 2013-08-23 Isoxazolidine derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018109262A Division JP6736607B2 (ja) 2012-09-13 2018-06-07 イソキサゾリジン誘導体

Publications (2)

Publication Number Publication Date
JP2015533801A JP2015533801A (ja) 2015-11-26
JP2015533801A5 true JP2015533801A5 (ja) 2018-03-01

Family

ID=47044778

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015531511A Pending JP2015533801A (ja) 2012-09-13 2013-08-23 イソキサゾリジン誘導体
JP2018109262A Expired - Fee Related JP6736607B2 (ja) 2012-09-13 2018-06-07 イソキサゾリジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018109262A Expired - Fee Related JP6736607B2 (ja) 2012-09-13 2018-06-07 イソキサゾリジン誘導体

Country Status (28)

Country Link
US (2) US9155747B2 (ja)
EP (1) EP2895495B1 (ja)
JP (2) JP2015533801A (ja)
KR (1) KR101719524B1 (ja)
CN (2) CN104619714A (ja)
AR (1) AR092547A1 (ja)
AU (1) AU2013314539B2 (ja)
BR (1) BR112015005500B1 (ja)
CA (1) CA2884705C (ja)
CL (1) CL2015000610A1 (ja)
EA (1) EA027034B1 (ja)
ES (1) ES2672140T3 (ja)
GE (1) GEP201706708B (ja)
HK (1) HK1209756A1 (ja)
IL (1) IL237686A (ja)
MA (1) MA37927B2 (ja)
MX (1) MX364865B (ja)
MY (1) MY182523A (ja)
NZ (1) NZ705902A (ja)
PE (1) PE20150675A1 (ja)
PH (1) PH12015500534B1 (ja)
PL (1) PL2895495T3 (ja)
SA (1) SA515360134B1 (ja)
SG (1) SG11201501902RA (ja)
TN (1) TN2015000093A1 (ja)
UA (1) UA116545C2 (ja)
WO (1) WO2014040837A1 (ja)
ZA (1) ZA201501691B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103391945B (zh) 2011-03-15 2016-11-09 奇斯药制品公司 异噁唑烷衍生物
SG10202110259QA (en) 2017-10-05 2021-10-28 Fulcrum Therapeutics Inc Use of p38 inhibitors to reduce expression of dux4
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31997A (en) * 1968-05-03 1974-03-14 Lepetit Spa Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
SE378110B (ja) * 1972-05-19 1975-08-18 Bofors Ab
JPS617293A (ja) * 1984-06-20 1986-01-13 Mitsubishi Chem Ind Ltd 新規なコルチコイド誘導体およびその製法
US5888995A (en) * 1991-02-04 1999-03-30 Astra Aktiebolag Steroid esters
WO2003070745A2 (en) * 2002-02-20 2003-08-28 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
NO331891B1 (no) * 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
US20110294766A1 (en) * 2008-02-27 2011-12-01 Astrazeneca Ab 16 Alpha, 17 Alpha-Acetal Glucocorticosteroidal Derivatives and their Use
JP2013504524A (ja) 2009-09-11 2013-02-07 シエシー ファルマセウティチィ ソシエタ ペル アチオニ イソオキサゾリジン誘導体
TW201139369A (en) 2010-02-05 2011-11-16 Chiesi Farma Spa Pyrrolidine derivatives
CN103391945B (zh) 2011-03-15 2016-11-09 奇斯药制品公司 异噁唑烷衍生物
WO2012123493A2 (en) 2011-03-15 2012-09-20 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives
EP2739640A1 (en) 2011-08-01 2014-06-11 Chiesi Farmaceutici S.p.A. Anti -inflammatory steroids condensed in position 16,17 with pyrrolidine ring

Similar Documents

Publication Publication Date Title
JP2015522045A5 (ja)
JP2016028092A5 (ja)
JP2015125255A5 (ja)
EA201600091A1 (ru) 4-членные кольцевые карбоксамиды, применяемые в качестве нематоцидов
JP2015537008A5 (ja)
JP2015512883A5 (ja)
EA201591805A1 (ru) Оксабицикло [2.2.2] кислоты - модуляторы gpr120
JP2014526533A5 (ja)
JP2015199738A5 (ja)
JP2015537124A5 (ja)
JP2015533801A5 (ja)
JP2015016294A5 (ja)
JP2015514574A5 (ja)
JP2017037280A5 (ja)
JP2015030781A5 (ja)
JP2013129650A5 (ja)
JP2014526458A5 (ja)
JP2015044793A5 (ja) 有機化合物
TWD174422S (zh) 置物藍(九)
TWD174423S (zh) 置物藍(十)
CN302517205S (zh) 控制柜(1)
CN302517204S (zh) 控制柜(2)
CN302078277S (zh) 门帘(玫瑰)
CN302390669S (zh) 门把手(ctls-20121023-002)
CN302393180S (zh) 家庭网关(10g epon)